Speculating here. If one trial if one trial in Europe is the outcome - and seems due "in next few weeks" (given hx likely in December) - what do you think the market will do? On one hand, we have appx 60% of addressable market in the EU and a quicker path to commercialisation event.
One the other hand FDA seems to be a key to the market opinion.
My opinion, will be a decent but not over the top re-rate to if one trial in EU. Appx $1.
I think this firms as the likely scenario.
Like to hear your thoughts.
- Forums
- ASX - By Stock
- IXC
- Ann: Notice of Investor Call and Presentation
Ann: Notice of Investor Call and Presentation, page-115
-
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.463M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 77245 | 8.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 5755 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 77245 | 0.083 |
2 | 137000 | 0.082 |
1 | 84879 | 0.076 |
1 | 6693 | 0.075 |
1 | 500000 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 5755 | 1 |
0.095 | 100000 | 1 |
0.100 | 2750 | 1 |
0.150 | 713 | 1 |
0.000 | 0 | 0 |
Last trade - 10.04am 21/10/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online